Citadel Advisors »

Eyepoint Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $41M 1.8M 23.11
2023-09-30 $9.2M 1.1M 7.99
2023-06-30 $7.6M 868k 8.70
2023-03-31 $2.7M 926k 2.94
2022-12-31 $2.0M 574k 3.50
2022-06-30 $8.3M 1.1M 7.87
2022-03-31 $18M 1.5M 12.15
2021-12-31 $19M 1.5M 12.24
2021-09-30 $10M 995k 10.41
2021-06-30 $9.4M 1.0M 9.00
2021-03-31 $11M 1.1M 10.17
2020-12-31 $91k 14k 6.56